Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.Howard A. Burris, Daniel D. Von Hoff, M. Christine Cripps et al.|Journal of Clinical Oncology|1997Cited by 5.9k
Matrix Metalloproteinases: Biologic Activity and Clinical ImplicationsAmy R. Nelson, Lynn M. Matrisian, Mace L. Rothenberg et al.|Journal of Clinical Oncology|2000Cited by 1.6k
A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancerMace L. Rothenberg, Daniel D. Von Hoff, Malcolm J. Moore et al.|Annals of Oncology|1996Cited by 569